Futurity: Research NewsTinkering with T-cells aims them at deadly brain cancerFuturity: Research NewsIn this study, CSPG4 was highly expressed in 67 percent of the brain cancer samples, leading the researchers to believe this could be a more effective … Continue reading
CRISPR-Cas9 scissors can cut through both DNA and RNAZME ScienceCRISPR-Cas9 technology has the potential to dramatically alter our environment and livelihoods. This powerful tool can cut out portions of DNA — the molecule that contains the blueprint of… Continue reading
Johns Hopkins researchers invent new technology for cancer immunotherapyEurekAlert (press release)Johns Hopkins researchers have invented a new class of cancer immunotherapy drugs that are more effective at harnessing the power of the immune system to … Continue reading
OncLiveOptimizing Immunotherapy in Lung CancerOncLiveOncLive: Can you give an overview of your presentation? Denham: My topic lays the groundwork for a lot of the others—it is the use of immunotherapy, largely anti–PD-1 therapy, for NSCLC. I reviewed t… Continue reading
California Healthline |
Paltry First Stem Cell Royalty Check A ‘Mile Marker’ And Not The Destination, Officials Say
California Healthline Taxpayers voted to fund the California Institute for Regenerative Medicine to the tune of $3 billion. Years later, the first royalty check is in, and it’s not exactly impressing critics. Sacramento Bee: California Collects First Royalty Check From $3 … |
Labiotech.eu (blog) |
Doudna and Charpentier Get Second CRISPR Patent in Europe
Labiotech.eu (blog) Just a month after the European Patent Office revoked a CRISPR patent from Doudna and Charpentier’s competitors, they’ve been granted a second patent that covers a new form of the popular gene editing tool. The European Patent Office has granted CRISPR … |
Labiotech.eu (blog) |
Doudna and Charpentier Get Second CRISPR Patent in Europe
Labiotech.eu (blog) Just a month after the European Patent Office revoked a CRISPR patent from Doudna and Charpentier’s competitors, they’ve been granted a second patent that covers a new form of the popular gene editing tool. The European Patent Office has granted CRISPR … |